Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.95
-2.60 (-15.71%)
At close: Oct 13, 2026, 4:00 PM EDT
13.96
+0.01 (0.07%)
After-hours: Oct 13, 2026, 5:32 PM EDT
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $37.27. The average 1-year stock price forecast is 167.17% higher than the current stock price, while the lowest is $23 (+64.87%) and the highest is $57 (+308.60%).
Price Target: $37.27 (+167.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $57 | Buy | Maintains | $57 | +308.60% | Oct 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $26 → $23 | Buy | Maintains | $26 → $23 | +64.87% | Oct 13, 2026 |
| Barclays | Barclays | Buy Maintains $37 | Buy | Maintains | $37 | +165.23% | Oct 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $38 | Buy | Maintains | $38 | +172.40% | Oct 12, 2026 |
| UBS | UBS | Buy Reiterates $37 → $33 | Buy | Reiterates | $37 → $33 | +136.56% | Aug 21, 2026 |
Financial Forecast
Revenue This Year
314.11M
from 172.35M
Increased by 82.25%
Revenue Next Year
459.12M
from 314.11M
Increased by 46.17%
EPS This Year
-1.98
from -3.29
EPS Next Year
-0.84
from -1.98
EPS and Forward PE are based on non-GAAP adjusted numbers.